ERBITUX

Welcome to the Brand page for “ERBITUX”, which is offered here for The mark comprises the word erbitux and an antibody design.;pharmaceutical preparation, monoclonal antibody for the treatment of cancer;color is not claimed as a feature of the mark.;.

Its status is currently believed to be active. Its class is unavailable. “ERBITUX” is believed to be currently owned by “IMCLONE SYSTEMS INCORPORATED”.


Owner:
IMCLONE SYSTEMS INCORPORATED
Owner Details
Description:
The mark comprises the word ERBITUX and an antibody design.;PHARMACEUTICAL PREPARATION, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER;Color is not claimed as a feature of the mark.;
Categories: MARK COMPRISES WORD